Normal view MARC view ISBD view

Oxidation and melting of aluminum nanopowders. [electronic resource]

By:

Trunov, Mikhaylo A

Contributor(s):

Producer: 20070723Description: 13094-9 p. digitalISSN:

1520-6106

Online resources:

Available from publisher's website

In: The journal of physical chemistry. B vol. 110

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 Mining our ABCs: pharmacogenomic approach for evaluating transporter function in cancer drug resistance.
by Ross, Douglas D
2 Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
by Doyle, L Austin
3 Telomerase as a diagnostic and therapeutic target for cancer.
by Doyle, L Austin
4 Lung cancer in women: emerging differences in epidemiology, biology, and therapy.
by Thomas, Leno
5 Phase 2 study of cryptophycin 52 (LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer.
by Edelman, Martin J
6 Phase II trial of the novel retinoid, bexarotene, and gemcitabine plus carboplatin in advanced non-small-cell lung cancer.
by Edelman, Martin J
7 Quantitative analysis of breast cancer resistance protein and cellular resistance to flavopiridol in acute leukemia patients.
by Nakanishi, Takeo
8 Phase II trial of gemcitabine/carboplatin followed by paclitaxel in patients with performance status=2,3 or other significant co-morbidity (HIV infection or s/p organ transplantation) in advanced non-small cell lung cancer.
by Bridges, Benjamin B
9 Exposure-Response Analysis of Alvocidib (Flavopiridol) Treatment by Bolus or Hybrid Administration in Newly Diagnosed or Relapsed/Refractory Acute Leukemia Patients.
by LaCerte, Carl
10 High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival.
by Kwong, King F
11 Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group.
by Wagner, Lars M
12 Functional characterization of human breast cancer resistance protein (BCRP, ABCG2) expressed in the oocytes of Xenopus laevis.
by Nakanishi, Takeo
13 Cetuximab with concurrent chemoradiation for esophagogastric cancer: assessment of toxicity.
by Safran, Howard
14 Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiation.
by Krasna, Mark J
15 A phase II trial of the epothilone B analog ixabepilone (BMS-247550) in patients with metastatic melanoma.
by Ott, Patrick A
16 Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer.
by Do, Khanh
17 Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium.
by Smith, Sonali M
18 Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal carcinoma (NCT 01283035).
by Lee, Elizabeth K
19 Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer.
by Edelman, Martin J
20 A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group study.
by Fouladi, Maryam